Cite
MLA Citation
Stefan Willmann et al.. “PK/PD modeling of FXI antisense oligonucleotides to bridge the dose‐FXI activity relation from healthy volunteers to end‐stage renal disease patients.” CPT: pharmacometrics & systems pharmacology, vol. 10, 2021, pp. 890–901. http://access.bl.uk/ark:/81055/vdc_100140212427.0x00000a